
- /
- Supported exchanges
- / XETRA
- / ZOE.XETRA
Zoetis Inc (ZOE XETRA) stock market data APIs
Zoetis Inc Financial Data Overview
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Zoetis Inc data using free add-ons & libraries
Get Zoetis Inc Fundamental Data
Zoetis Inc Fundamental data includes:
- Net Revenue: 9 256 M
- EBITDA: 3 891 M
- Earnings Per Share: 5
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-11
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Zoetis Inc News

Zoetis Inc (ZTS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations
Revenue: $9.3 billion for the year, growing 8% on a reported basis and 11% operationally. Adjusted Net Income: $2.7 billion, growing 10% on a reported basis and 15% operationally. Companion Animal Por...


Q4 2024 Zoetis Inc Earnings Call
Participants Steven Frank; VP of Investor Relations; Zoetis Inc Kristin Peck; Chief Executive Officer, Director; Zoetis Inc Wetteny Joseph; Chief Financial Officer, Executive Vice President; Zoetis...

Why Zoetis (ZTS) Shares Are Falling Today
Why Zoetis (ZTS) Shares Are Falling Today What Happened? Shares of animal health company Zoetis (NYSE:ZTS) fell 10.6% in the morning session after the company reported disappointing fourth-quarter r...

Zoetis Stock Down Despite Q4 Earnings & Revenues Beat Estimates
Zoetis, Inc. ZTS delivered fourth-quarter 2024 adjusted earnings (excluding one-time items) of $1.40 per share, which surpassed the Zacks Consensus Estimate of $1.37. In the year-ago quarter, the comp...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.